TXGNasdaq United States
Market cap
$6.606 B
$52.03 +14.10%
Close of 7 Aug 2026
Revenue
$642.8M
#1789 by revenue
Earnings
-$43.5M
Loss-making
Shares outstanding
127,691,329
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for 10x Genomics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.